ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Rheumatoid Arthritis

RA Mobile Apps: The Top 19

In this slideshow, we highlight the best of rheumatoid arthritis mobile apps designed to track disease activity. The list, a total of 19, is based on a scientific review published in February. (©Ymgerman/Shutterstock.com)

Rheumatoid Arthritis

@ImagePointFR/Shutterstock.com

Tocilizumab added to methotrexate suppresses inflammation as compared to tocilizumab alone after inadequate methotrexate response.

Early stage RA treated with tocilizumab or tocilizumab and methotrexate realized clinical benefits with no safety concerns at two years.

Chronic pain (©Lightspring/Shutterstock.com)

DMARDs and surgery are unlikely to be effective as sole therapies when central pain vs. peripheral pain is suspected in lupus, RA and osteoarthritis.

(©TimMasters/Shutterstock.com)

The FDA has nixed Eli Lilly's and Inctye's application for baricitinib in its current form asking for additional safety and clinical data.

Blood vessels (©Vlue/Shutterstock.com)

Mayo Clinic’s Dr. Eric Matteson and Dr. Sharon Chung of UCSF provide an update on advances in new treatments for vasculitis.

(©BillionPhotos/Shutterstock.com)

Researchers are suggesting the adoption of triple therapy as a first-line treatment after RA patients fail methotrexate monotherapy.

Lymphoma cancer cell (©Royaltystockphoto/Shutterstock.com)

Malignant lymphoma proves to be a difficult adversary in rheumatoid arthritis, despite TNFi therapy, a study shows.

Pages

Subscribe to Rheumatoid Arthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.